Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Jeselhy (pimitespib)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Otsuka

Drug class:

HSP90 inhibitor

Related drugs:

KIT mutation	Gastrointestinal Stromal Tumor	KIT mutation	Gastrointestinal Stromal Tumor	pimitespib Sensitive: B - Late Trials pimitespib Sensitive : B	pimitespib Sensitive: B - Late Trials pimitespib Sensitive : B
MSI-H/dMMR	Colorectal Cancer	MSI-H/dMMR	Colorectal Cancer	nivolumab + pimitespib Sensitive: C3 – Early Trials nivolumab + pimitespib Sensitive : C3	nivolumab + pimitespib Sensitive: C3 – Early Trials nivolumab + pimitespib Sensitive : C3
TMB-H + PD-L1 expression	Colorectal Cancer	TMB-H + PD-L1 expression	Colorectal Cancer	nivolumab + pimitespib Sensitive: C3 – Early Trials nivolumab + pimitespib Sensitive : C3	nivolumab + pimitespib Sensitive: C3 – Early Trials nivolumab + pimitespib Sensitive : C3
PDGFRA D842V	Gastrointestinal Stromal Tumor	PDGFRA D842V	Gastrointestinal Stromal Tumor	pimitespib Sensitive: C4 – Case Studies pimitespib Sensitive : C4	pimitespib Sensitive: C4 – Case Studies pimitespib Sensitive : C4
KIT D818Y	Gastrointestinal Stromal Tumor	KIT D818Y	Gastrointestinal Stromal Tumor	pimitespib Sensitive: D – Preclinical pimitespib Sensitive : D	pimitespib Sensitive: D – Preclinical pimitespib Sensitive : D